Lasa Total Liab vs Cash And Short Term Investments Analysis

LASA Stock   27.18  0.76  2.72%   
Lasa Supergenerics financial indicator trend analysis is infinitely more than just investigating Lasa Supergenerics recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Lasa Supergenerics is a good investment. Please check the relationship between Lasa Supergenerics Total Liab and its Cash And Short Term Investments accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lasa Supergenerics Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Total Liab vs Cash And Short Term Investments

Total Liab vs Cash And Short Term Investments Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Lasa Supergenerics Total Liab account and Cash And Short Term Investments. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between Lasa Supergenerics' Total Liab and Cash And Short Term Investments is -0.52. Overlapping area represents the amount of variation of Total Liab that can explain the historical movement of Cash And Short Term Investments in the same time period over historical financial statements of Lasa Supergenerics Limited, assuming nothing else is changed. The correlation between historical values of Lasa Supergenerics' Total Liab and Cash And Short Term Investments is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Liab of Lasa Supergenerics Limited are associated (or correlated) with its Cash And Short Term Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash And Short Term Investments has no effect on the direction of Total Liab i.e., Lasa Supergenerics' Total Liab and Cash And Short Term Investments go up and down completely randomly.

Correlation Coefficient

-0.52
Relationship DirectionNegative 
Relationship StrengthVery Weak

Total Liab

The total amount of all liabilities that a company has, including both short-term and long-term liabilities.

Cash And Short Term Investments

Short Term Investments is an account in the current assets section of Lasa Supergenerics balance sheet. This account contains Lasa Supergenerics investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Lasa Supergenerics Limited fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.
Most indicators from Lasa Supergenerics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Lasa Supergenerics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lasa Supergenerics Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Tax Provision is likely to gain to about 27.5 M in 2024, whereas Selling General Administrative is likely to drop slightly above 29 M in 2024.
 2021 2022 2023 2024 (projected)
Depreciation And Amortization145.1M134.2M106.7M116.9M
Interest Income403K41.6M37.4M46.9M

Lasa Supergenerics fundamental ratios Correlations

-0.79-0.930.91-0.610.660.790.92-0.81-0.41-0.94-0.45-0.560.42-0.72-0.19-0.160.49-0.90.710.34-0.91-0.90.51-0.57-0.95
-0.790.7-0.80.84-0.22-0.81-0.560.980.60.670.720.81-0.140.97-0.110.47-0.230.87-0.21-0.080.610.81-0.040.220.79
-0.930.7-0.860.54-0.83-0.82-0.950.690.330.990.370.44-0.420.620.190.04-0.470.93-0.81-0.270.990.92-0.720.690.97
0.91-0.8-0.86-0.460.480.730.84-0.84-0.58-0.85-0.65-0.410.13-0.68-0.03-0.10.25-0.920.690.14-0.85-0.810.44-0.65-0.84
-0.610.840.54-0.46-0.22-0.76-0.380.770.40.550.290.97-0.40.87-0.150.62-0.420.620.01-0.220.410.750.05-0.040.72
0.66-0.22-0.830.48-0.220.560.84-0.20.02-0.840.1-0.110.54-0.17-0.350.190.53-0.60.860.35-0.86-0.680.94-0.68-0.74
0.79-0.81-0.820.73-0.760.560.75-0.8-0.39-0.8-0.45-0.70.33-0.810.3-0.570.4-0.830.480.27-0.74-0.840.38-0.58-0.86
0.92-0.56-0.950.84-0.380.840.75-0.58-0.25-0.96-0.31-0.320.36-0.47-0.230.010.41-0.840.90.26-0.97-0.80.76-0.77-0.9
-0.810.980.69-0.840.77-0.2-0.8-0.580.670.660.770.76-0.10.95-0.130.5-0.220.86-0.26-0.120.620.78-0.050.280.77
-0.410.60.33-0.580.40.02-0.39-0.250.670.30.560.460.260.49-0.180.340.130.54-0.150.060.310.41-0.020.190.4
-0.940.670.99-0.850.55-0.84-0.8-0.960.660.30.280.45-0.490.590.20.03-0.540.89-0.82-0.330.980.93-0.720.680.97
-0.450.720.37-0.650.290.1-0.45-0.310.770.560.280.30.420.68-0.120.260.290.65-0.110.270.360.330.110.220.34
-0.560.810.44-0.410.97-0.11-0.7-0.320.760.460.450.3-0.290.83-0.160.7-0.320.540.09-0.170.310.640.16-0.120.64
0.42-0.14-0.420.13-0.40.540.330.36-0.10.26-0.490.42-0.29-0.23-0.07-0.110.98-0.160.30.86-0.37-0.550.37-0.18-0.47
-0.720.970.62-0.680.87-0.17-0.81-0.470.950.490.590.680.83-0.23-0.180.6-0.320.78-0.1-0.20.520.760.040.140.73
-0.19-0.110.19-0.03-0.15-0.350.3-0.23-0.13-0.180.2-0.12-0.16-0.07-0.18-0.69-0.010.1-0.280.160.260.05-0.33-0.190.15
-0.160.470.04-0.10.620.19-0.570.010.50.340.030.260.7-0.110.6-0.69-0.180.150.3-0.3-0.070.210.38-0.020.18
0.49-0.23-0.470.25-0.420.530.40.41-0.220.13-0.540.29-0.320.98-0.32-0.01-0.18-0.250.340.92-0.43-0.610.37-0.26-0.52
-0.90.870.93-0.920.62-0.6-0.83-0.840.860.540.890.650.54-0.160.780.10.15-0.25-0.63-0.060.90.89-0.50.570.92
0.71-0.21-0.810.690.010.860.480.9-0.26-0.15-0.82-0.110.090.3-0.1-0.280.30.34-0.630.27-0.88-0.590.91-0.88-0.68
0.34-0.08-0.270.14-0.220.350.270.26-0.120.06-0.330.27-0.170.86-0.20.16-0.30.92-0.060.27-0.25-0.390.26-0.29-0.3
-0.910.610.99-0.850.41-0.86-0.74-0.970.620.310.980.360.31-0.370.520.26-0.07-0.430.9-0.88-0.250.86-0.80.740.92
-0.90.810.92-0.810.75-0.68-0.84-0.80.780.410.930.330.64-0.550.760.050.21-0.610.89-0.59-0.390.86-0.520.50.97
0.51-0.04-0.720.440.050.940.380.76-0.05-0.02-0.720.110.160.370.04-0.330.380.37-0.50.910.26-0.8-0.52-0.76-0.58
-0.570.220.69-0.65-0.04-0.68-0.58-0.770.280.190.680.22-0.12-0.180.14-0.19-0.02-0.260.57-0.88-0.290.740.5-0.760.54
-0.950.790.97-0.840.72-0.74-0.86-0.90.770.40.970.340.64-0.470.730.150.18-0.520.92-0.68-0.30.920.97-0.580.54
Click cells to compare fundamentals

Lasa Supergenerics Account Relationship Matchups

Lasa Supergenerics fundamental ratios Accounts

201920202021202220232024 (projected)
Common Stock Shares Outstanding22.7M22.9M40.7M50.1M57.6M39.2M
Total Assets2.3B2.1B2.0B1.6B1.5B1.7B
Short Long Term Debt Total484.9M194.6M201.7M217.7M220.8M209.7M
Other Current Liab60.8M63.4M76.7M114.2M127.4M79.0M
Total Current Liabilities759.2M405.4M435.7M427.3M488.7M531.6M
Total Stockholder Equity1.4B1.6B1.5B1.2B966.8M1.3B
Other Liab3.6M4.6M84.1M70.0M80.5M84.6M
Net Tangible Assets990.2M1.4B1.5B1.4B1.7B1.3B
Property Plant And Equipment Net1.5B1.4B1.2B927.8M863.3M1.1B
Current Deferred Revenue75.8M77.2M73.3M(217.7M)226K214.7K
Net Debt459.3M156.2M91.3M209.7M214.7M428.2M
Retained Earnings32.8M207.3M144.1M(253.7M)(469.8M)(446.3M)
Accounts Payable337.3M127.2M169.1M94.3M140.5M219.8M
Cash25.7M38.4M110.4M8.0M6.1M5.8M
Non Current Assets Total1.6B1.4B1.3B1.2B1.1B1.2B
Non Currrent Assets Other(1.5B)5.9M(5K)1K7.1M7.5M
Other Assets39.3M5.9M(1K)1K900.0855.0
Cash And Short Term Investments25.7M38.4M171.9M23.9M15.0M14.2M
Net Receivables206.5M147.7M185.6M24.8M36.4M34.6M
Liabilities And Stockholders Equity2.3B2.1B2.0B1.6B1.5B1.7B
Non Current Liabilities Total146.0M84.1M70.0M28.4M53.2M50.6M
Inventory263.0M172.6M115.0M139.0M190.4M195.3M
Other Current Assets263.5M279.0M251.8M229.3M137.7M242.3M
Total Liab905.2M489.4M505.7M455.7M541.9M764.1M
Short Long Term Debt343.5M194.6M201.7M217.7M220.8M244.4M
Total Current Assets758.7M643.2M719.3M392.2M378.9M564.0M
Accumulated Other Comprehensive Income(501.7M)(673.5M)555.4M515.8M593.1M622.8M
Cash And Equivalents34.9M5.6M61.5M15.9M18.3M21.8M
Short Term Debt324.3M174.5M201.7M217.7M220.8M214.8M
Intangible Assets62.3M54.5M44.7M185.3M142.6M93.0M
Property Plant Equipment1.5B1.4B1.2B927.8M835.0M1.1B
Net Invested Capital1.9B1.6B1.5B1.2B1.2B1.3B
Net Working Capital(454K)237.9M283.6M(35.1M)(109.8M)(104.3M)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Lasa Stock Analysis

When running Lasa Supergenerics' price analysis, check to measure Lasa Supergenerics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lasa Supergenerics is operating at the current time. Most of Lasa Supergenerics' value examination focuses on studying past and present price action to predict the probability of Lasa Supergenerics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lasa Supergenerics' price. Additionally, you may evaluate how the addition of Lasa Supergenerics to your portfolios can decrease your overall portfolio volatility.